Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHollywood Bwl Regulatory News (BOWL)

Share Price Information for Hollywood Bwl (BOWL)

Share Price is delayed by 15 minutes
Get Live Data
282.00    -4.50 (-1.57%)
Bid:
282.00
Ask:
284.00
Spread: 2.00 (0.709%)
Market Cap: £472.75m
BOWL Live PriceLast checked at - London Stock Exchange

Intraday Hollywood Bwl Share Chart

Director/PDMR Shareholding

8 Jun 2026 11:50

RNS Number : 4259H
Hollywood Bowl Group plc
08 June 2026
 

 8 June 2026

Hollywood Bowl Group plc

 

Notification of Transactions by Persons Discharging Managerial Responsibility ("PMDRs") and their Closely Associated Persons ("PCA")

 

The Company announces that Laurence Keen (CEO, Canada and a PDMR) has transferred 120,000 Ordinary Shares of £0.01 each to his spouse (Pippa Keen) for nil consideration. There is no net change in Laurence Keen's beneficial interest in shares in the Company (including shares held by his wife) which remains at 1,389,501 shares (0.83% of issued share capital):

 

The notification below, made in accordance with Article 19 of the UK Market Abuse Regulation, provides further detail.

 

Enquiries:

 

Hollywood Bowl Group plc - Via Headland

Stephen Burns, Chief Executive Officer

Antony Smith, Chief Financial Officer

Mat Hart, Business Development Director

 

Headland

Rosh Field / Antonia Pollock

hollywoodbowl@headlandconsultancy.com

+44 (0)20 3805 4822

 

 

 

1.

Details of PDMR / person closely associated with them ('PCA')

a)

Name

Laurence Keen

2.

Details of PDMR / person closely associated with them ('PCA')

a)

Position / status

CEO, Canada

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Hollywood Bowl Group plc

b)

LEI

213800XB8YZNGJYDEZ97

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument;(ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary shares of £0.01 each

 

ISIN: GB00BD0NVK62

b)

Nature of the transaction

Share transfer to spouse for nil consideration

 

c)

Price(s) and volume(s)

 

 

 

 

Price(s)

Volume(s)

Nil

120,000

d)

Aggregated information

 

Aggregated volume

 

Price

 

 

N/A - Single transaction

e)

Date of the transaction

8 June 2026

 

f)

Place of the transaction

Outside a trading venue

 

 

 

1.

Details of PDMR / person closely associated with them ('PCA')

a)

Name

Pippa Keen

2.

Details of PDMR / person closely associated with them ('PCA')

a)

Position / status

PCA of Laurence Keen (CEO, Canada)

b)

Initial notification / amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Hollywood Bowl Group plc

b)

LEI

213800XB8YZNGJYDEZ97

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument;(ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument

Ordinary shares of £0.01 each

 

ISIN: GB00BD0NVK62

b)

Nature of the transaction

Share transfer from spouse for nil consideration

 

c)

Price(s) and volume(s)

 

 

 

 

Price(s)

Volume(s)

Nil

120,000

d)

Aggregated information

 

Aggregated volume

 

Price

 

 

N/A - Single transaction

e)

Date of the transaction

8 June 2026

 

f)

Place of the transaction

Outside a trading venue

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHBGGDLCSGDGLI
Date   Source Headline
29th Jan 202111:26 amRNSResult of AGM
28th Jan 20216:12 pmRNSHolding(s) in Company
18th Jan 20217:00 amRNSDirector/PDMR Shareholding
5th Jan 20219:39 amRNSDirector/PDMR Shareholding
23rd Dec 202010:15 amRNSAnnual Financial Report and Notice of AGM
14th Dec 20207:00 amRNSFinal Results - Year Ended 30 September 2020
27th Nov 20203:59 pmRNSNotice of Results
15th Oct 20207:00 amRNSTrading Statement - Year Ended 30 September 2020
30th Sep 20204:35 pmRNSPrice Monitoring Extension
14th Aug 20205:39 pmRNSCentre reopening update
6th Aug 20207:00 amRNSBlock listing Interim Review
31st Jul 20204:33 pmRNSDelay to reopening of English centres
17th Jul 20203:53 pmRNSCentre reopening update
30th Jun 20204:36 pmRNSPrice Monitoring Extension
26th Jun 20203:48 pmRNSHolding(s) in Company
16th Jun 20205:17 pmRNSHolding(s) in Company
10th Jun 20201:18 pmRNSHolding(s) in Company
9th Jun 20208:47 amRNSHolding(s) in Company
1st Jun 20207:00 amRNSHalf-year Results
12th May 20209:29 amRNSUpdate and Notice of Results
12th May 20207:00 amRNSUpdate and Notice of Results
17th Apr 202012:53 pmRNSDirector/PDMR Shareholding
17th Apr 202011:55 amRNSResults of Placing
17th Apr 20207:00 amRNSProposed Placing of New Ordinary Shares
6th Apr 20204:37 pmRNSPrice Monitoring Extension
3rd Apr 20204:41 pmRNSSecond Price Monitoring Extn
3rd Apr 20204:36 pmRNSPrice Monitoring Extension
2nd Apr 20207:00 amRNSFurther actions in response to COVID-19
1st Apr 202012:03 pmRNSPrice Monitoring Extension
20th Mar 20204:43 pmRNSSecond Price Monitoring Extn
20th Mar 20204:36 pmRNSPrice Monitoring Extension
19th Mar 20204:43 pmRNSSecond Price Monitoring Extn
19th Mar 20204:37 pmRNSPrice Monitoring Extension
17th Mar 20204:40 pmRNSStatement on COVID-19
16th Mar 20207:00 amRNSDirector/PDMR Shareholding
16th Mar 20207:00 amRNSDirector/PDMR Shareholding
9th Mar 202012:54 pmRNSDirector/PDMR Shareholding
6th Mar 20209:03 amRNSHolding(s) in Company
2nd Mar 20201:17 pmRNSDirector/PDMR Shareholding
26th Feb 20209:58 amRNSHolding(s) in Company
6th Feb 20204:38 pmRNSDirector/PDMR Shareholding
6th Feb 20209:10 amRNSGrant of Options under SAYE Scheme
4th Feb 20208:53 amRNSAdditional Listing
30th Jan 20201:51 pmRNSResult of AGM
20th Jan 202012:30 pmRNSDirector/PDMR Shareholding
7th Jan 20204:54 pmRNSDirector/PDMR Shareholding
23rd Dec 201910:32 amRNSAnnual Financial Report and Notice of AGM
20th Dec 201912:23 pmRNSHolding(s) in Company
13th Dec 20197:00 amRNSFinal Results - Year Ended 30 September 2019
12th Nov 20194:51 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.